PharmaLeaders published “The Role of AI in Precision Medicine: The Right Drug for the Right Patient at the Right Time,” featuring AiCure’s Chief Medical Officer, Rich Christie, in a forward-looking piece on AI’s unique potential to transform drug development through precision medicine by delivering the timely, accurate behavioral insights needed to drive informed interventions, understand which patients will be able to contribute quality data for specific studies, and bridge clinical findings in an increasingly diverse real-world environment.
-
Share
-
Recent Press
-
May 29, 2025
AiCure Appoints Sabina Chadha as CEO, Ed Ikeguchi Transitions to Chief Medical Officer, and Josh Wilson Promoted to COO and President
-
Nov 28, 2024
Clinical Research, Inequality and the Future of Women’s Health
-
Oct 21, 2023
From Guidelines to Standards: Why Comprehensive AI Regulation is Essential to Spurring Innovation
-
May 29, 2025